Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

White Pearl Technology Group publish Annual Report 2023

The annual report refers to the White Pearl Technology Group AB operations during the period January 1, 2023 through december 31, 2023.White Pearl Technology Group (WPTG), organisation no. 556939-8752, is a Swedish public limited company whose shares of series B are admitted to trading on Nasdaq First North Growth Market Sweden and are traded under the ticker WPTG B with ISIN code SE0019762477, since 29 th of June 2023. White Pearl Technology Group refer to the holding company and the 28 subsidaries in 2023 (thirthy subsidairies in 2024) that are part of the company group. AGM will be

BioStock: Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0”

BioInvent recently announced promising clinical data for its lead cancer immunotherapy candidates, BI-1808 and BI-1206. The company hosted a Key Opinion Leader webinar to explain the results in detail, featuring insights from internationally recognized oncologist Dr Alexander Eggermont. According to Dr Eggermont, BioInvent’s candidates hold great promise for the future of immuno-oncology.Read the article at biostock.se: Top oncologist underscores BioInvent’s potential for “Immunotherapy 2.0” - BioStock 

Zeqmelit® Planned to be Available in Pharmacies Starting September 1

The medication Zeqmelit® is planned to be available in pharmacies in Sweden from September 1, 2024. Launches in Norway and Finland are expected to follow shortly thereafter. In parallel, pre-launch activities are underway to prepare the market for an effective launch.AcuCort’s medication Zeqmelit® – a fast-dissolving oral film placed on the tongue for the treatment of severe to acute allergy –is currently in an intensive commercialization phase. Based on extensive pre-launch activities, the planned launch will take place on September 1, 2024, making the product available to patients. The

Bruhn NewTech welcomes Adelis Equity as partner and majority shareholder in the first step towards the creation of a leading European technology defence group

Bruhn NewTech, the leading provider of CBRN knowledge management software, announces Adelis Equity as new majority shareholder. Adelis will, through Adelis Equity Partners Fund III AB, support Bruhn NewTech in its next stage of its growth and product development. Bruhn NewTech marks the first milestone in Adelis’ establishment of a company group of leading niche software companies to support the protection of people and societies.Bruhn NewTech, the Danish provider of knowledge management software that increases societies readiness towards chemical, biological, radiological and nuclear (CBRN)

Compliance with Market Abuse Regulations

1 July 2024   Fidelity European Trust PLC (“the Company”)   LEI: 549300UC0QPP7Y0W8056   Compliance with Market Abuse Regulations   The Company wishes to notify the market that the closed period of the Company in relation to its half-yearly results for the period ending 30 June 2024 will commence on 1 July 2024 (today) and is anticipated to end no sooner than 31 July 2024.   The Company confirms that all inside information (as defined in the UK Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory

Compliance with Market Abuse Regulations

Fidelity Emerging Markets Ltd (“the Company”)   Compliance with Market Abuse Regulations     The Company wishes to notify the market that the closed period of the Company in relation to its annual results for the period ended 30 June 2024 will commence on 9 September 2024 and is anticipated to end no sooner than 9 October 2024.   The Company confirms that all inside information (as defined in the UK Market Abuse Regulation) which the Directors and the Company may have held has been notified to a regulatory information service.  Accordingly, in the absence of any new

Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call

Getinge will issue its Q2 Report 2024 on July 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.Fund managers, analysts and media are invited to participate in the conference call. To participate via teleconference, please register via this link . After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

Remedy Entertainment Plc: Share subscriptions based on stock options 2018 and 2019

Remedy Entertainment Plc     Stock exchange release       July 1, 2024, 9:00 a.m. EEST   Share subscriptions based on stock options 2018 and 2019 Between April 1 and May 31, 2024, a total of 16,500 Remedy Entertainment Plc’s new shares has been subscribed for with the company’s stock options 2018 and 2019. For subscriptions made with the stock options 2018 and 2019, the entire subscription price of EUR 120,250.00 will be entered in the reserve for invested unrestricted equity. After the trade registration the total amount of shares is 13,569,151. The shares subscribed for

Image System's business area RemaSawco receives an order from a Canadian partner of just under SEK 2.2 million

RemaSawco works with a partner in Canada who has now signed an agreement with a Canadian customer where RemaSawco's order value amounts to just under SEK 2.2 millionFor several years now, RemaSawco has collaborated with a partner in Canada for the North American market who has now signed an agreement with an end customer in Canada. RemaSawco's part of the agreement concerns the licensing of RemaSawco's world-leading system for board scanning, RS-BoardScannerQ, which can be used in all parts of the board handling process at a sawmill. The agreement also includes technical support during

Invitation to presentation of Orkla’s second quarter 2024 results, Monday 15 July

Orkla will report its second quarter 2024 results on Monday, 15 July 2024 at 7:00 a.m. CEST.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The quarterly results will be presented at 8:00 a.m. CEST at the Orkla House, Drammensveien 149, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at https://investors.orkla.com (direct link: https://events.webcast.no/orkla-asa-1/presentations/SLTf8NDZ4QJum9joxmgo) or followed by telephone (listen only): Dial-in details:

Events during the second quarter, 2024

During the quarter, Wallenstam started the construction of 408 apartments in Årstaberg, Stockholm. In addition, Wallenstam has acquired land in Älta, Nacka, and sold building rights in Umami Park, Sundbyberg.An inauguration ceremony for the construction of the 408 apartments in Årstaberg, Stockholm, took place in May with Magdalena Andersson, leader of the Swedish Social Democratic party, and CEO Hans Wallenstam as well as invited guests. All in all, Wallenstam had 1,238 apartments under construction as of June 30, 2024. In April, Wallenstam acquired land, Nacka Älta 69:4, from Nacka

NCC to deck over the Göta Tunnel in Gothenburg

In partnership with the Swedish Transport Administration, NCC is decking over the western mouth of the Göta Tunnel and constructing a ventilation tower in order to facilitate further development of the Masthuggskajen district. The order value is approximately SEK 175 million. Image: NCC The Göta Tunnel is one of the most important in Gothenburg, with its on- and off-ramps comprising barriers to traffic that make it difficult to get to and from Göta älv from the city center. Decking over the western on- and off-ramps will create spaces that link Göta älv with the Järntorget and

Buyback update

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union Withdrawal Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.   1 July 2024   Menhaden Resource Efficiency plc   Buyback update   The Board of Menhaden Resource Efficiency plc (the “Company” or “MHN”) announces a recommencement of its share buyback programme in light of the Company’

Transaction in Own Shares

     1 July 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |28/06/2024|+--------------------------------------------------------------

Christer Hansson appointed permanent CEO

Storskogen Group AB (publ) (“Storskogen”) announces today that Christer Hansson is appointed permanent CEO, after serving as interim CEO since 19 February 2024.Today, Storskogen’s Board of Directors announces that interim CEO Christer Hansson is appointed permanent CEO after a thorough recruitment process conducted throughout the spring. “During this rigorous recruitment process, we have considered a number of strong candidates for the CEO role. While we knew that Christer would effectively assume the role as interim CEO, we have been particularly impressed by his ability to drive

Africa Oil Announces Results of Share Buyback Program and Provides Share Capital and Voting Rights Update

VANCOUVER, BC, July 1, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 432,200 Africa Oil common shares during the period of June 24, 2024 to June 25, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/1052 (

Africa Energy Announces Block 11B/12B Operations Update

VANCOUVER, BC, July 1, 2024 /CNW/ - Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”) announces that CNR International (South Africa) Limited (“CNR”) has provided notice to the joint venture partners that it will withdraw from its 20% interest in accordance with the joint operating agreement in respect of Block 11B/12B, Offshore the Republic of South Africa (“JOA”). Under the JOA, the other parties to the joint venture may advise whether or not they will also withdraw within 30 days. Withdrawing parties assign their interest free of

Lynparza & Imfinzi positive CHMP in endometrial

1 July 2024 Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for patients with mismatch repair proficient advanced or recurrent endometrial cancer Imfinzi also recommended for patients with mismatch repair deficient disease Recommendation based on DUO-E Phase III results, which showed both regimens demonstrated statistically significant and clinically meaningful improvement in progression-free survival vs. chemotherapy alone AstraZeneca's Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU) as

iLOQ Annual and Sustainability Report 2023 has been published

iLOQ takes a holistic 360-degree approach to sustainability. This means looking at all ESG factors not only in the company’s day-to-day operations, but across the entire supply chain and throughout the lifecycle of its solutions. Continuous development of the circular economy and sustainable performance is an important part of iLOQ’s strategy. iLOQ’s audited Annual and Sustainability report has been published in English https://www.iloq.com/en/sustainability/ More information Erja Sankari, Chief Operating Officer, erja.sankari@iloq.com, Tel. +358 (0) 44 435 2382 Minna

Eevia Health secures an 868 KSEK sales order from a new customer for a new superior polyphenol extract

Eevia Health Plc (”Eevia” or ”The Company”) has won a 77 KEUR (868 KSEK) sales order from a new North American brand owner. The order is the first commercial customer for Feno-Cerasus™ 50 Organic, a new tart cherry extract product with the highest concentration of polyphenols when  compared to competitive Tart Cherry extracts.The end customer, a North American brand owner headquartered in the Mid-West US, is a fast-growing brand dedicated to organic, clean ingredients in its consumer products. They market dietary supplements and health foods across the US through different channels and

New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register

OPTOMED PLC STOCK EXCHANGE RELEASE 1 July 2024, at 8:30 a.m. EEST   New shares subscribed for in Optomed Plc’s directed share issue have been registered in the Finnish Trade Register A total of 1,500,000 new shares subscribed for in Optomed Plc’s directed share issue have been registered into the Finnish Trade Register today, on 1 July 2024. After the registration of the new shares, the company will have 19,630,397 shares in total of which 353,973 shares in treasury.   The new shares produce the right to dividends and other distribution of assets as well as other shareholder

There are no items matching the current filter
There are no more items matching the current filter
Back to top